IL10 and malaria: IL-10 was also decreased in PDL1-IgG1Fc-treated ECM mice compared with the “PbANKA” group, consistent with an epidemiological investigation in Malian children by Lyke et al which showed a significantly elevated level of IL-10 in severe malaria vs. uncomplicated malaria controls (4).